Compare Cigna Corp (CI) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs 10X Genomics Inc — how do they compare? Cigna Corp trades at $302.09 (market cap $80.55B), while 10X Genomics Inc trades at $45.99 (market cap $5.30B). The key difference: Cigna Corp is far larger — about 15.2× 10X Genomics Inc's market cap, and Cigna Corp pays a 2.05% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| CI | TXG | |
|---|---|---|
Market Cap | $80.55B | $5.30B |
Sector | Health | Health |
52-Week High | $311.00 | $45.80 |
52-Week Low | $244.41 | $11.34 |
Enterprise Value | $103.65B | $4.85B |
Dividend Yield | 2.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
